Sonoma Pharmaceuticals (SNOA) announced the registration of its hypochlorous acid-based acne products with the Medicines & Healthcare products Regulatory Agency to be sold through a U.K. health and beauty retailer and pharmacy chain across more than 1,200 stores throughout the United Kingdom.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNOA:
- 3 Penny Stocks to Watch Now, 3/11/25